Small Volume Injectables Methylene Blue Injection
Secured the FDA approval letter on December 23, 2025, achieving U.S. marketing approval. FDA-approved indication: the treatment of pediatric and adult patients with acquired methemoglobinemia.
La tua richiesta va direttamente al fornitore interessato — il nostro team ti ricontatta entro 24 ore.
Grazie — il nostro team ti risponderà entro 24 ore.